City
Epaper

Pharmacy and Biotechnology students of Chandigarh University gets placed in top pharmaceutical multinationals

By ANI | Updated: May 26, 2020 15:51 IST

With India ranking third globally in the production of medicines and largest producer of generic medicines, the pharmaceutical sector of the country has grown in leaps and bounds during the last two decades.

Open in App

With India ranking third globally in the production of medicines and largest producer of generic medicines, the pharmaceutical sector of the country has grown in leaps and bounds during the last two decades.

Attributing to the growth of Indian Pharmaceutical Industry, the number of jobs in the sector has seen a big surge which can be verified from the fact that more than 80 Multi-National Compes have recruited 300 Biotechnology and 150 pharmacy students of Chandigarh University. The placements data was released by Vice-Chancellor, Chandigarh University, Dr RS Bawa.

"Recruitment of pharmacy and biotechnology at Chandigarh University have witnessed a surge of 20 per cent during the last three years and the number of offers has also seen a jump of 15 per cent," said Dr Bawa, while giving details about the placements.

"Top pharma compes like Abbott Pharmacy, Cipla, Johnson & Johnson, Wockhardt, Torrent Pharma, Glenmark, IDS Infotech, OMICS India, Panacea Biotech have been the major recruiters of the Biotechnology and Pharmacy students and IDS Infotech and OMICS India have emerged as the top recruiters with 14 and 12 selections respectively," further added the Vice-Chancellor.

Fortis Hospital, Medanta, Apollo Hospitals, Jaypee Hospital, Dr Lal Path Labs are some of the healthcare sector compes which have offered placements to the students of Chandigarh University, Vice-Chancellor added.

"CU has been very aggressive in encouraging the students for taking-up research especially in the field of healthcare and medicines which has resulted in selection of more than 35 students by top Government Research Institutions which includes CSIR- Indian Institute of Integrative Medicine, National Institute of Biologicals, National Agri-Biotechnology Institute (NABI), CSIR-Institute of Himalayan Biotechnology, Central Drug Standard Control Orgzation (CDSCO), Food Corporation of India (FCI) and MILKFED," further mentioned Dr Bawa.

The selected students are working as research scholars, project assistants, quality control officers at different Government Research Institutions, he added.

"Our Biotechnology and Pharmacy students are doing exceptional work in research and have managed to file 25 patents in the field of Medical Instruments, Formulations and Medical Compounds for Asthama and Cancer Drugs and others during the last five years," said Satnam Singh Sandhu, Chancellor, Chandigarh University.

"This has encouraged the global giants like Abbott Pharma, Cipla, Wockhardt to offer jobs to our biotechnology and pharmacy students as they are well acclimatize to the working culture of the Global Pharma Industry," he added.

This story is provided by PRNewswire. will not be responsible in any way for the content of this article. (/PRNewswire)

( With inputs from ANI )

Tags: Indian pharmaceutical industrySatnam singh sandhuCsir
Open in App

Related Stories

NationalCSIR NET Result 2025 Announced at csirnet.nta.ac.in; Here’s How to Check

NationalUGC NET 2024: NTA Announces New Date for June Session Exam - Details Inside

NTA Postpones Joint CSIR-UGC-NET June 2024 Exam Due to Unavoidable Circumstances and Logistic Issues

NationalWho Is Satnam Singh Sandhu? Know About Chandigarh University Chancellor Who Nominated to Rajya Sabha

National"Startups Intellectual Property Rights Protection" is aimed at promoting innovation and entrepreneurship: Jitendra Singh

Business Realted Stories

BusinessGold prices slip over Rs 3,000 per 10 grams as global sentiment turns weak

BusinessAdani Total Gas clocks 19 pc growth in revenue from operations in Q2, volume up 16 pc

BusinessTVS Motor registers 29% revenue growth and posts highest ever sales, revenue and profits in Q2FY26

BusinessIndian aviation industry to incur net losses up to Rs 105 billion in FY26: ICRA

BusinessPM Modi Recognizes Content Creator Yash Salunke for Promoting Sanskrit on Social Media